Skip to Content



Pfizer vaccine expands to U.S. children as young as 12

May 11, 2021 00:00 AM UTC
- Updated May 11, 2021 15:58 PM UTC

FDA has approved emergency use authorization for children ages 12 to 15.

today, we're very pleased to learn that the FDA has approved emergency use authorization uh, for the B. N. T. 162 B two vaccine to be used in Children 12 to 15 years of age. So this is a watershed moment in our ability to fight back the covid 19 pandemic. We actually had higher antibody responses in the 12-15 year olds. So that gives us real confidence. We hope to have some data in the Lebanon under by the fall, Perhaps as early as the end of the year would be in a position where that vaccine could be made available. Uh at least of the 5 to 11 year olds, if not younger age groups, but certainly by the early part of next year, Children right now are struggling, particularly in those years when they're normally dealing with team sports, team activities, drama, club, things that require people gathering together that the vaccine has the potential to be liberated right now, with everybody getting vaccinated. Uh, those school activities can open up in addition to the schools themselves.